PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31601046-6	2019	CD40L/interleukin 4 (IL4) co-treatment mimicking the CLL microenvironment increased resistance to IDE, but synergy was retained.	idelalisib	98-101	CD40 ligand	Homo sapiens	0-5	
20522708-8	2010	In addition, CAL-101 abrogated protection from spontaneous apoptosis induced by B cell-activating factors CD40L, TNF-alpha, and fibronectin.	idelalisib	13-20	CD40 ligand	Homo sapiens	106-111	
28462919-6	2017	CD40L/IL-21-induced proliferation could be inhibited by idelalisib and ibrutinib.	idelalisib	56-66	CD40 ligand	Homo sapiens	0-5